Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Common bladder drug may ease kidney stone surgery

NCT ID NCT07566416

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 131 people having surgery for kidney stones. Some were already taking mirabegron for overactive bladder, which relaxes the ureter. Researchers wanted to see if this helped surgeons insert a tube more easily and caused less injury. The idea is that a relaxed ureter might make the procedure smoother.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mirabegron
What this could lead to
If it works, this could make kidney stone surgery easier and safer by relaxing the ureter, potentially reducing complications.
What could go wrong
This is a small, retrospective study, not a controlled trial. Results may not apply to everyone, and mirabegron's effect on surgery success is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

131 people

The number who actually took part.

Started

Jan 2018

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients scheduled for RIRS due to kidney stones

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients scheduled for RIRS due to kidney stones Exclusion Criteria: * preoperative ureteral stenting, * ureteral strictures, history of ureteral or bladder surgery, * anatomical abnormalities of the urinary tract, * active urinary tract infection, * pregnancy, * uncontrolled hypertension (systolic blood pressure ≥180 mmHg, diastolic blood pressure ≥110 mmHg), * use of medications affecting ureteral smooth muscle tone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney stone are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Training and Research Hospital

    Ankara, Altındağ, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.